Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers

NCT02849977 is registered in ClinicalTrials.gov with Rhythm Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02849977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Lead sponsor
Rhythm Pharmaceuticals, Inc.
Phase
Observational
Overall status
Completed
Start date
September 28, 2016
Completion date
June 9, 2020
Enrollment
5,966 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

pro-opiomelanocortin (pomc), proprotein convertase subtilisin/kexin type 1 (pcsk1) and leptin receptor (lepr) gene mutations